bluebird bio, Inc. ( BLUE) - Key Metrics
Stock symbol BLUE is outdated, potentially delisted? Maybe it is available on other exchange?
BLUE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | $3.96 | -$2.95 | -$5.16 | -$5.21 |
| 2024Q3 | $0.05 | -$0.31 | -$0.36 | -$0.36 |
| 2024Q2 | $0.08 | -$0.42 | -$0.34 | -$0.34 |
| 2024Q1 | $0.10 | -$0.36 | -$0.39 | -$0.40 |
| 2023Q4 | $0.07 | -$0.75 | -$0.12 | -$0.16 |
BLUE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | -0.71 |
| 2024Q3 | ? | -8.28 |
| 2024Q2 | ? | -11.61 |
| 2024Q1 | ? | -17.16 |
| 2023Q4 | ? | -9.24 |
BLUE
Price: $4.97
52 week price:
Earnings Per Share: -20.59 USD
P/E Ratio: -0.24
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.0 million
Ebitda: -74.0 millionMarket Capitalization: 48.7 million